Reuters logo
SGS and Bavarian Nordic developing challenge strain to combat respiratory virus​
October 12, 2017 / 6:01 AM / 5 days ago

SGS and Bavarian Nordic developing challenge strain to combat respiratory virus​

ZURICH (Reuters) - SGS and Bavarian Nordic are teaming up to develop a virus challenge strain to combat a common respiratory illness.

The companies aim to develop the respiratory syncytial virus challenge strain in order to help advance progress towards a universal vaccine against the virus, SGS said in a statement on Thursday.

RSV is a significant cause of respiratory illness in all agegroups, and is the most common cause of lower respiratorytract infections in children worldwide, resulting in a high number of hospitalizations.

SGS cited WHO estimates which said RSV infects more than 64 million people globally each year and causes a similar number of deaths to those caused by influenza.

Reporting by Brenna Hughes Neghaiwi, editing by John Revill

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below